🧪 Clinical Development
This section covers corporate investment behaviour of pharmaceutical companies, not the efficacy or safety of any medicinal product. Headlines are quoted as published; no claim about product performance is made or implied by this site. Collection and classification are automated and may misclassify or miss items. Disclaimer
🧬 Drug Discovery74
🧪 Clinical Development3
📑 CTD / Regulatory Submission1
🩺 GCP Operations0
📘 ICH Guidelines & AI0
🛡️ Pharmacovigilance / GVP0
📊 RWE / Evidence Generation1
🎓 Medical Affairs0
💼 Sales1
📣 Marketing0
🚚 Distribution / Supply Chain3
✅ GQP / Quality Assurance1
👥 Human Resources2
💴 Finance & Accounting0
🏛️ Enterprise AI Platform & Governance151
- 2026-09-30S4 Amount disclosedRoche Pours $2.4 Billion into Autonomous AI Lab as Phase III Success Rate Jumps to 80%$2.4 Billion — finance.biggo.com09/30 14:25 JSTRoche
- 2026-09-30S2 Deal / PartnershipAbbVie Inc. (ABBV) Partners With Valkai to Apply AI in Clinical Development — TradingView09/29 22:00 JSTAbbVieAlso reported by 1: marketscreener.com
- 2026-09-17S2 Deal / PartnershipGC Cell Signs Joint Research Agreement with AI Clinical Trial Simulation Company 'QuantHealth' — 아시아경제09/16 09:14 JST